Aneel A. Ashrani, M.D., M.S.

Closed for Enrollment

• A Phase III Open-Label Multi-Center Study Of The Pharmacokinetics, Safety, And Efficacy Of Coagadex In The Treatment Of Adults With Acquired Factor X Deficiency Associated With Light Chain Amyloidosis Scottsdale/Phoenix, AZ Rochester, MN The purpose of this study is to evaluate the efficacy and safety of Coagadex in treating active bleeds and to manage peri-operative bleeding in participants with acquired factor X deficiency associated with AL amyloidosis.
• Plasma and Serum Bank for Patients with Thrombosis Rochester, MN

  The purpose of this study is to create and maintain a clinical database of patients with history of, or who are at high risk for thromboembolic diseases, along with a plasma/serum repository. We plan to evaluate novel biomarkers that might be associated with thromboembolic diseases and test whether these biomarkers will help predict the incident and recurrentrecurrences of thromboembolic episodes and other outcomes (e.g., mortality, post thrombotic syndrome).